Cancer Causes & Control

, Volume 27, Issue 3, pp 301–323 | Cite as

Risk factors for Barrett’s esophagus: a scoping review

  • Colin J. Ireland
  • Sarah K. Thompson
  • Thomas A. Laws
  • Adrian Esterman
Review article

Abstract

Introduction

Cancer of the esophagus is a highly lethal disease with many patients presenting with metastatic spread of their tumor at diagnosis; a consequence of this late presentation is the 5-year survival rate of <20 %. Barrett’s esophagus (BE), a premalignant condition of the distal esophagus, is the main risk factor for adenocarcinoma of the esophagus. The development of a risk prediction tool that could assist healthcare professionals in identifying people at increased risk of developing BE would be advantageous. Understanding the factors that influence the risk of developing BE is the first stage of developing a risk prediction tool.

Methods

A scoping review was undertaken to address the following question ‘what factors influence the risk of developing Barrett’s esophagus?’ Forty-six articles were included in this review.

Results

The majority of articles reviewed were case–control or cohort studies. Samples sizes ranged from 68 to 84,606. Risk factors reported to be statistically significant were divided into three categories: demographic, lifestyle and clinical factors. Strongest risk factors identified include: male gender, increasing age, white race, smoking, obesity and gastro-esophageal reflux disease symptoms, while some aspects of a person’s diet appear to act as a protective measure.

Conclusion

Risk factors for BE are complex and need to be considered by healthcare professionals when identifying patients that could benefit from endoscopic eradication. These results provide a stepping stone for the future development of a risk prediction model.

Keywords

Barrett’s esophagus Scoping review Risk factors Cancer Risk prediction 

References

  1. 1.
    Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC (2012) A clinical risk prediction model for Barrett esophagus. Cancer Prev Res 5(9):1115–1123. doi:10.1158/1940-6207.CAPR-12-0010 CrossRefGoogle Scholar
  2. 2.
    Thrift AP, Whiteman DC (2012) The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 23(12):3155–3162. doi:10.1093/annonc/mds181 CrossRefPubMedGoogle Scholar
  3. 3.
    Stavrou EP, McElroy HJ, Baker DF, Smith G, Bishop JF (2009) Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972–2005. Med J Aust 191(6):310–314PubMedGoogle Scholar
  4. 4.
    Australian Institute of Health and Welfare (AIHW) (2015) Australian Cancer Incidence and Mortality (ACIM) books: oesophageal cancer. AIHW. http://www.aihw.gov.au/acim-books. Accessed 25 May 2015
  5. 5.
    Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT (2011) Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol 26:739–745. doi:10.1007/s10654-011-9596-z CrossRefPubMedGoogle Scholar
  6. 6.
    De Jonge PJF, Van Blankenstein M, Grady WM, Kuipers EJ (2014) Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut 63(1):191–202. doi:10.1136/gutjnl-2013-305490 CrossRefPubMedGoogle Scholar
  7. 7.
    Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O’Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J (2014) British society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63(1):7–42. doi:10.1136/gutjnl-2013-305372 CrossRefPubMedGoogle Scholar
  8. 8.
    Fass R, Sampliner RE (2003) Barrett’s oesophagus: optimal strategies for prevention and treatment. Drugs 63(6):555–564. doi:10.2165/00003495-200363060-00003 CrossRefPubMedGoogle Scholar
  9. 9.
    Rubenstein JH (2014) Risk factors for Barrett’s esophagus. Current Opin Gastroenterol 30(4):408–414. doi:10.1097/MOG.0000000000000084 CrossRefGoogle Scholar
  10. 10.
    Zimmerman TG (2014) Common questions about Barrett esophagus. Am Fam Phys 89(2):92–98Google Scholar
  11. 11.
    Atkinson M, Chak A (2010) Screening for Barrett’s esophagus. Tech Gastrointest Endosc 12:62–66. doi:10.1016/j.tgie.2010.02.009 PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, Allen JI, Brill JV, Pruitt RE, Kahrilas PJ, Peters JH, Nix K, Montgomery EA, Mitchell BD, Yao J (2011) American gastroenterological association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140:1084–1091. doi:10.1053/j.gastro.2011.01.030 CrossRefPubMedGoogle Scholar
  13. 13.
    Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P (2012) Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the american college of physicians. Ann Intern Med 157(11):808–817CrossRefPubMedGoogle Scholar
  14. 14.
    Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J, Eslick GD, Gordon LG, Grimpen F, Hebbard G, Holliday L, Hourigan LF, Kendall BJ, Lee EYT, Levert-Mignon A, Lord RV, Lord SJ, Maule D, Moss A, Norton I, Olver I, Pavey D, Raftopoulos S, Rajendra S, Schoeman M, Singh R, Sitas F, Smithers BM, Taylor AC, Thomas ML, Thomson I, To H, von Dincklage J, Vuletich C, Watson DI, Yusoff IF (2015) Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 30(5):804–820. doi:10.1111/jgh.12913 CrossRefPubMedGoogle Scholar
  15. 15.
    Locke GR, Zinsmeister AR, Talley NJ (2003) Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 58(5):661–670CrossRefPubMedGoogle Scholar
  16. 16.
    Gerson LB, Edson R, Lavori PW, Triadafilopoulos G (2001) Use of a simple symptom questionnaire to predict Barrett’s esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 96(7):2005–2012CrossRefPubMedGoogle Scholar
  17. 17.
    Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, McMahon LF Jr, Metko V, Near E, Kellenberg J, Kalish T, Inadomi JM (2013) Prediction of Barrett’s esophagus among men. Am J Gastroenterol 108(3):353–362. doi:10.1038/ajg.2012.446 PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Melnikov A, Scholtens D, Godwin A, Levenson V (2009) Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn 11(1):60–65. doi:10.2353/jmoldx.2009.080072 PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Rosen D, Wang L, Atkinson J, Yub Y, Lud K, Diamandis E, Hellstrom I, Mokg S, Liua J, Bast R (2005) Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol 99:267–277. doi:10.1016/j.ygyno.2005.06.040 CrossRefPubMedGoogle Scholar
  20. 20.
    Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8(1):19–32. doi:10.1080/1364557032000119616 CrossRefGoogle Scholar
  21. 21.
    Steevens J, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, van den Brandt PA (2011) A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 20(2):345–358. doi:10.1158/1055-9965.EPI-10-0636 CrossRefPubMedGoogle Scholar
  22. 22.
    Jacobson BC, Chan AT, Giovannucci EL, Fuchs CS (2009) Body mass index and Barrett’s oesophagus in women. Gut 58(11):1460–1466. doi:10.1136/gut.2008.174508 PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Liu X, Wong A, Kadri SR, Corovic A, O’Donovan M, Lao-Sirieix P, Lovat LB, Burnham RW, Fitzgerald RC (2014) Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett’s esophagus. PLoS ONE. doi:10.1371/journal.pone.0094163 Google Scholar
  24. 24.
    Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797. doi:10.1111/j.1572-0241.2008.01835.x CrossRefPubMedGoogle Scholar
  25. 25.
    Eloubeidi MA, Provenzale D (2001) Clinical and demographic predictors of Barrett’s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33(4):306–309CrossRefPubMedGoogle Scholar
  26. 26.
    Balasubramanian G, Singh M, Gupta N, Gaddam S, Giacchino M, Wani SB, Moloney B, Higbee AD, Rastogi A, Bansal A, Sharma P (2012) Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy. Am J Gastroenterol 107(11):1655–1661. doi:10.1038/ajg.2012.299 CrossRefPubMedGoogle Scholar
  27. 27.
    Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB (2013) Age at onset of GERD symptoms predicts risk of Barrett’s esophagus. Am J Gastroenterol 108(6):915–922. doi:10.1038/ajg.2013.72 PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Kramer JR, Fischbach LA, Richardson P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Velez M, Cole R, Anand B, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB (2013) Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett’s esophagus in white men. Clin Gastroenterol Hepatol 11(4):373–381. doi:10.1016/j.cgh.2012.11.028 PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Lin D, Kramer JR, Ramsey D, Alsarraj A, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB (2013) Oral bisphosphonates and the risk of Barrett’s esophagus: case–control analysis of US veterans. Am J Gastroenterol 108(10):1576–1583. doi:10.1038/ajg.2013.222 PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA, Group FS (2010) Risk of Barrett’s oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Scand J Gastroenterol 45(12):1397–1403. doi:10.3109/00365521.2010.503968 CrossRefPubMedGoogle Scholar
  31. 31.
    Ibiebele TI, Hughes MC, Nagle CM, Bain CJ, Whiteman DC, Webb PM (2013) Dietary antioxidants and risk of Barrett’s esophagus and adenocarcinoma of the esophagus in an Australian population. Int J Cancer 133(1):214–224. doi:10.1002/ijc.28016 CrossRefPubMedGoogle Scholar
  32. 32.
    Kendall BJ, MacDonald GA, Hayward NK, Prins JB, O’Brien S, Whiteman DC (2013) The risk of Barrett’s esophagus associated with abdominal obesity in males and females. Int J Cancer 132(9):2192–2199. doi:10.1002/ijc.27887 PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Kendall BJ, Macdonald GA, Prins JB, O’Brien S, Whiteman DC, Green AC, Hayward NK, Parsons PG, Pavey SJ, Purdie DM, Webb PM, Gotley D, Smithers BM, Jamieson GG, Drew P, Watson DI, Clouston A (2014) Total body fat and the risk of Barrett’s oesophagus: a bioelectrical impedance study. Cancer Epidemiol 38(3):266–272. doi:10.1016/j.canep.2014.03.006 PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P (2005) Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett’s esophagus. Am J Epidemiol 162(5):454–460CrossRefPubMedGoogle Scholar
  35. 35.
    Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S (2005) Socioeconomic status in health research: one size does not fit all. JAMA 294(22):2879–2888CrossRefPubMedGoogle Scholar
  36. 36.
    Campos GM, DeMeester SR, Peters JH, Oberg S, Crookes PF, Hagen JA, Bremner CG, Sillin LF 3rd, Mason RJ, DeMeester TR (2001) Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 136(11):1267–1273CrossRefPubMedGoogle Scholar
  37. 37.
    Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL (2009) Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case–control study. Am J Gastroenterol 104(4):834–842. doi:10.1038/ajg.2009.137 PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Xiong LS, Cui Y, Wang JP, Wang JH, Xue L, Hu PJ, Chen MH (2010) Prevalence and risk factors of Barrett’s esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J Dig Dis 11(2):83–87. doi:10.1111/j.1751-2980.2010.00419.x CrossRefPubMedGoogle Scholar
  39. 39.
    Mathew P, Joshi AS, Shukla A, Bhatia SJ (2011) Risk factors for Barrett’s esophagus in Indian patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 26(7):1151–1156. doi:10.1111/j.1440-1746.2011.06714.x CrossRefPubMedGoogle Scholar
  40. 40.
    Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson D, Willis J, Grady WM, Falk GW, Cooper GS, Li L, Chak A (2012) Association of insulin and insulin-like growth factors with Barrett’s oesophagus. Gut 61(5):665–672. doi:10.1136/gutjnl-2011-300641 PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Omer ZB, Ananthakrishnan AN, Nattinger KJ, Cole EB, Lin JJ, Kong CY, Hur C (2012) Aspirin protects against Barrett’s esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol 10(7):722–727. doi:10.1016/j.cgh.2012.02.031 PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Jonaitis L, Kriukas D, Kiudelis G, Kupcinskas L (2011) Risk factors for erosive esophagitis and Barrett’s esophagus in a high Helicobacter pylori prevalence area. Med (Kaunas) 47(8):434–439Google Scholar
  43. 43.
    Keyashian K, Hua V, Narsinh K, Kline M, Chandrasoma PT, Kim JJ (2013) Barrett’s esophagus in Latinos undergoing endoscopy for gastroesophageal reflux disease symptoms. Dis Esophagus 26(1):44–49. doi:10.1111/j.1442-2050.2011.01316.x CrossRefPubMedGoogle Scholar
  44. 44.
    Kamat P, Wen S, Morris J, Anandasabapathy S (2009) Exploring the association between elevated body mass index and Barrett’s esophagus: a systematic review and meta-analysis. Ann Thorac Surg 87(2):655–662. doi:10.1016/j.athoracsur.2008.08.003 CrossRefPubMedGoogle Scholar
  45. 45.
    Iyer PG, Borah BJ, Heien HC, Das A, Cooper GS, Chak A (2013) Association of Barrett’s esophagus with type II diabetes mellitus: results from a large population-based case–control study. Clin Gastroenterol Hepatol 11(9):1108–1114. doi:10.1016/j.cgh.2013.03.024 CrossRefPubMedGoogle Scholar
  46. 46.
    Kubo A, Cook MB, Shaheen NJ, Vaughan TL, Whiteman DC, Murray L, Corley DA (2013) Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s oesophagus: a pooled analysis from the international BEACON consortium. Gut 62(12):1684–1691. doi:10.1136/gutjnl-2012-303753 CrossRefPubMedGoogle Scholar
  47. 47.
    Andrici J, Cox MR, Eslick GD (2013) Cigarette smoking and the risk of Barrett’s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol (Aust) 28(8):1258–1273. doi:10.1111/jgh.12230 CrossRefGoogle Scholar
  48. 48.
    Balasubramanian G, Gupta N, Giacchino M, Singh M, Kanakadandi V, Gaddam S, Wani SB, Higbee AD, Rastogi A, Bansal A, Sharma P (2013) Cigarette smoking is a modifiable risk factor for Barrett’s oesophagus. United Eur Gastroenterol J 1(6):430–437. doi:10.1177/2050640613504917 CrossRefGoogle Scholar
  49. 49.
    Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, Nyren O (2007) Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol 42(2):148–156CrossRefPubMedGoogle Scholar
  50. 50.
    Akiyama T, Inamori M, Iida H, Mawatari H, Endo H, Hosono K, Yoneda K, Fujita K, Yoneda M, Takahashi H, Goto A, Abe Y, Kobayashi N, Kubota K, Saito S, Nakajima A (2008) Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett’s epithelium in Japanese men. BMC Gastroenterol. doi:10.1186/1471-230x-8-58 PubMedCentralPubMedGoogle Scholar
  51. 51.
    Veugelers PJ, Porter GA, Guernsey DL, Casson AG (2006) Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 19(5):321–328. doi:10.1111/j.1442-2050.2006.00602.x CrossRefPubMedGoogle Scholar
  52. 52.
    Kubo A, Levin TR, Block G, Rumore GJ, Quesenberry CP Jr, Buffler P, Corley DA (2008) Dietary antioxidants, fruits, and vegetables and the risk of Barrett’s esophagus. Am J Gastroenterol 103(7):1614–1623. doi:10.1111/j.1572-0241.2008.01838.x PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Corley DA, Kubo A, Levin TR, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Block G (2008) Iron intake and body iron stores as risk factors for Barrett’s esophagus: a community-based study. Am J Gastroenterol 103(12):2997–3004. doi:10.1111/j.1572-0241.2008.02156.x PubMedCentralCrossRefPubMedGoogle Scholar
  54. 54.
    Jiao L, Kramer JR, Rugge M, Parente P, Verstovsek G, Alsarraj A, El-Serag HB (2013) Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett’s esophagus. Cancer Causes Control 24(5):1005–1014. doi:10.1007/s10552-013-0175-3 PubMedCentralCrossRefPubMedGoogle Scholar
  55. 55.
    Keszei AP, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, van den Brandt PA (2014) Vegetable, fruit and nitrate intake in relation to the risk of Barrett’s oesophagus in a large Dutch cohort. Br J Nutr 111(8):1452–1462. doi:10.1017/S0007114513003929 CrossRefPubMedGoogle Scholar
  56. 56.
    Katz PO, Gerson LB, Vela MF (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 18:308–328. doi:10.1038/ajg.2012.444 CrossRefGoogle Scholar
  57. 57.
    Gastroenterological Society of Australia (2011) Gastro-oesophageal reflux disease in adults - reflux disease, 5th edn. Gastroenterological Society of Australia, Victoria. http://www.gesa.org.au/files/editor_upload/File/Professional/Reflux_Disease.pdf. Accessed 10 May 2015
  58. 58.
    Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T (2010) Gallstones increase the prevalence of Barrett’s esophagus. J Gastroenterol 45(2):171–178. doi:10.1007/s00535-009-0153-4 CrossRefPubMedGoogle Scholar
  59. 59.
    Horna Strand A, Franzen T (2014) Influence of life style factors on Barrett’s oesophagus. Gastroenterol Res Pract. doi:10.1155/2014/408470 PubMedCentralPubMedGoogle Scholar
  60. 60.
    Andrici J, Tio M, Cox MR, Eslick GD (2013) Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol (Aust) 28(3):415–431. doi:10.1111/j.1440-1746.2012.07199.x CrossRefPubMedGoogle Scholar
  61. 61.
    Taylor JB, Rubenstein JH (2010) Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett’s esophagus. Am J Gastroenterol 105(8):1730–1737. doi:10.1038/ajg.2010.194 PubMedCentralCrossRefGoogle Scholar
  62. 62.
    Rubenstein JH, Morgenstern H, McConell D, Scheiman JM, Schoenfeld P, Appelman H, McMahon LF Jr, Kao JY, Metko V, Zhang M, Inadomi JM (2013) Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett’s esophagus. Gastroenterology 145(6):1237–1244. doi:10.1053/j.gastro.2013.08.052 PubMedCentralCrossRefPubMedGoogle Scholar
  63. 63.
    Gudlaugsdottir S, Verschuren WMM, Dees J, Stijnen T, Wilson JHP (2002) Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med 13(6):369–375. doi:10.1016/S0953-6205%2802%2900090-0 CrossRefPubMedGoogle Scholar
  64. 64.
    Leggett CL, Gorospe EC, Calvin AD, Harmsen WS, Zinsmeister AR, Caples S, Somers VK, Dunagan K, Lutzke L, Wang KK, Iyer PG (2014) Obstructive sleep apnea is a risk factor for Barrett’s esophagus. Clin Gastroenterol Hepatol 12(4):583–588. doi:10.1016/j.cgh.2013.08.043 PubMedCentralCrossRefPubMedGoogle Scholar
  65. 65.
    Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Parsonnet J (2008) Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut 57(6):727–733. doi:10.1136/gut.2007.132068 CrossRefGoogle Scholar
  66. 66.
    Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB (2014) Association between Helicobacter pylori and Barrett’s esophagus: a case–control study. Am J Gastroenterol 109(3):357–368. doi:10.1038/ajg.2013.443 PubMedCentralCrossRefPubMedGoogle Scholar
  67. 67.
    Greer KB, Kresak A, Bednarchik B, Dawson D, Li L, Chak A, Willis J (2013) Insulin/insulin-like growth factor-1 pathway in Barrett’s carcinogenesis. Clin Transl Gastroenterol 4:e31. doi:10.1038/ctg.2013.2 PubMedCentralCrossRefPubMedGoogle Scholar
  68. 68.
    Kramer JR, Arney J, Chen J, Richardson P, Duan Z, Street RL Jr, Hinojosa-Lindsey M, Naik AD, El-Serag HB (2012) Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res 12:288. doi:10.1186/1472-6963-12-288 PubMedCentralCrossRefPubMedGoogle Scholar
  69. 69.
    Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ (2011) American gastroenterological association technical review on the management of Barrett’s esophagus. Gastroenterology 140(3):e18–e52. doi:10.1053/j.gastro.2011.01.031 PubMedCentralCrossRefPubMedGoogle Scholar
  70. 70.
    Berkson J (1946) Limitations of the application of fourfold table analysis to hospital data. Biom Bull 2(3):47–53. doi:10.2307/3002000 CrossRefGoogle Scholar
  71. 71.
    Lim YC, Fitzgerald RC (2013) Diagnosis and treatment of Barrett’s oesophagus. Br Med Bull 107:117–132. doi:10.1093/bmb/ldt025 CrossRefPubMedGoogle Scholar
  72. 72.
    Gopal DV, Reichelderfer M, Gaumnitz EA, Harter J, Jobe BA (2004) Barrett’s esophagus: is screening and surveillance justified? Dis Manag Health Outcomes 12(6):353–361CrossRefGoogle Scholar
  73. 73.
    Sharma P, Sidorenko EI (2005) Are screening and surveillance for Barrett’s oesophagus really worthwhile? Gut 54(Suppl 1):i27–i32. doi:10.1136/gut.2004.041566 PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Colin J. Ireland
    • 1
  • Sarah K. Thompson
    • 2
  • Thomas A. Laws
    • 1
  • Adrian Esterman
    • 3
    • 4
  1. 1.School of Nursing and MidwiferyUniversity of South AustraliaAdelaideAustralia
  2. 2.Discipline of SurgeryUniversity of AdelaideAdelaideAustralia
  3. 3.Sansom Institute of Health Service Research and School of Nursing and MidwiferyUniversity of South AustraliaAdelaideAustralia
  4. 4.Centre for Chronic Disease PreventionJames Cook UniversityCairnsAustralia

Personalised recommendations